University of Lincoln
Browse

File(s) not publicly available

Epigenetic regulation of the placental HSD11B2 barrier and its role as a critical regulator of fetal development

Version 2 2024-03-12, 12:44
Version 1 2023-10-18, 08:42
journal contribution
posted on 2024-03-12, 12:44 authored by K. L. Togher, M. M. O'Keeffe, A. S. Khashan, Humberto Gutierrez, L. C. Kenny, G. W. O'Keeffe

Fetal programming is a term used to describe how early-life experience influences fetal development and later disease risk. In humans, prenatal stress-induced fetal programming is associated with increased risk of preterm birth, and a heightened risk of metabolic and neurological diseases later in life. A critical determinant of this is the regulation of fetal exposure to glucocorticoids by the placenta. Glucocorticoids are the mediators through which maternal stress influences fetal development. Excessive fetal glucocorticoid exposure during pregnancy results in low birth weight and abnormalities in a number of tissues. The amount of fetal exposure to maternal glucocorticoids depends on the expression of HSD11B2, an enzyme predominantly produced by the syncytiotrophoblast in the placenta. This protects the fetus by converting active glucocorticoids into inactive forms. In this review we examine recent findings regarding placental HSD11B2 that suggest that its epigenetic regulation may mechanistically link maternal stress and long-term health consequences in affected offspring. © 2014 Landes Bioscience.

History

School affiliated with

  • Department of Life Sciences (Research Outputs)

Publication Title

Epigenetics

Volume

9

Issue

6

Pages/Article Number

816-822

Publisher

Landes Bioscience

ISSN

1559-2294

eISSN

1559-2308

Date Submitted

2014-07-11

Date Accepted

2014-04-24

Date of First Publication

2014-04-24

Date of Final Publication

2014-04-24

ePrints ID

14389